COMP <GO>
ELAN vs JAZZ // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Elanco Animal Health Incorporated (NYSE) VS. Jazz Pharmaceuticals plc (Ireland) (NASDAQ) • 15-METRIC TALLY: ELAN 6
— JAZZ 4
■ METRIC PARITY
LAST: $24.10 (+4.51%) • MKT CAP: $11.52B
options-implied-move
—
LAST: $214.44 (-0.71%) • MKT CAP: $14.02B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ELAN VS. JAZZ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ELAN | JAZZ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.50% | -4.70% | +2.20 | ELAN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.45% | 9.61% | -7.16 | JAZZ | /fcf-yield <GO> |
| Operating Margin | -6.00% | -10.10% | +4.10 | ELAN | /operating-margins <GO> |
| Net Profit Margin | -4.90% | -8.30% | +3.40 | ELAN | /net-margins <GO> |
| Revenue Growth (YoY) | 6.20% | 4.90% | +1.30 | ELAN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.24 | 1.97 | -0.73 | JAZZ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.9 | 48.5 | +3.40 | ELAN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 1.09 | -0.13 | JAZZ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.0x | 36.0x | -16.00 | ELAN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.52B | $14.02B | -$2.50B | JAZZ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ELAN REV | JAZZ REV | ELAN GROSS % | JAZZ GROSS % | ELAN FCF | JAZZ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.71B | $4.27B | 55.0% | — | $284.0M | $1.30B |
| FY 2024 | $4.44B | $4.07B | 54.9% | — | $394.0M | $1.36B |
| FY 2023 | $4.42B | $3.83B | — | — | $72.2M | $919.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ELAN // BETA 0.96
JAZZ // BETA 1.09